XML 14 R4.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development $ 77,987 $ 60,806
General and administrative 27,873 13,922
Total operating expenses 105,860 74,728
Loss from operations (105,860) (74,728)
Other income:    
Other income, net 13,299 5,432
Total other income 13,299 5,432
Net loss $ (92,561) $ (69,296)
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (3.20) $ (3.29)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (3.20) $ (3.29)
Weighted average common shares outstanding, basic (in shares) 28,883,596 21,055,834
Weighted average common shares outstanding, diluted (in shares) 28,883,596 21,055,834